DaVita Inc. Peer Comparison
Metric | Value | Ranking | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $14.1 Billion | 2/13 | HCA $84.7B |
DVA $14.1B |
THC $12.0B |
UHS $11.8B |
EHC $9.9B |
ENSG $7.2B |
OPCH $5.4B |
ACHC $3.8B |
SGRY $3.3B |
AMED $3.0B |
USPH $1.3B |
AMN $911.9M |
CYH $453.0M |
Gross Margin | 34% | 8/13 | ACHC 96% |
HCA 85% |
AMED 77% |
UHS 72% |
EHC 46% |
THC 35% |
USPH 35% |
DVA 34% |
AMN 31% |
SGRY 23% |
CYH 21% |
OPCH 20% |
ENSG 15% |
Profit Margin | 7% | 4/13 | THC 13% |
EHC 9% |
ACHC 8% |
DVA 7% |
HCA 7% |
UHS 7% |
AMED 7% |
ENSG 7% |
OPCH 4% |
USPH 3% |
AMN 1% |
SGRY -4% |
CYH -13% |
EBITDA margin | 21% | 1/13 | DVA 21% |
ACHC 20% |
HCA 19% |
EHC 19% |
UHS 13% |
USPH 11% |
ENSG 11% |
THC 9% |
OPCH 8% |
AMED 4% |
AMN 3% |
CYH -4% |
SGRY -5% |
Quarterly Revenue | $3.3 Billion | 4/13 | HCA $17.5B |
THC $5.1B |
UHS $4.0B |
DVA $3.3B |
CYH $3.1B |
EHC $1.4B |
OPCH $1.3B |
ENSG $1.1B |
ACHC $815.6M |
SGRY $770.4M |
AMN $687.5M |
AMED $587.7M |
USPH $168.0M |
Quarterly Earnings | $214.7 Million | 4/13 | HCA $1.3B |
THC $681.0M |
UHS $258.7M |
DVA $214.7M |
EHC $120.9M |
ENSG $78.4M |
ACHC $68.1M |
OPCH $53.9M |
AMED $41.5M |
AMN $7.0M |
USPH $5.5M |
SGRY -$31.7M |
CYH -$391.0M |
Quarterly Free Cash Flow | $671.4 Million | 3/13 | HCA $2.3B |
THC $839.0M |
DVA $671.4M |
OPCH $150.7M |
AMED $104.2M |
ENSG $89.0M |
UHS $81.9M |
AMN $47.4M |
SGRY $45.0M |
USPH $19.1M |
CYH -$3.0M |
ACHC -$27.1M |
EHC -$0 |
Trailing 4 Quarters Revenue | $12.7 Billion | 4/13 | HCA $69.6B |
THC $21.0B |
UHS $15.4B |
DVA $12.7B |
CYH $12.6B |
EHC $5.4B |
OPCH $4.8B |
ENSG $4.1B |
ACHC $3.1B |
AMN $3.1B |
SGRY $3.0B |
AMED $2.3B |
USPH $622.4M |
Trailing 4 Quarters Earnings | $827.7 Million | 4/13 | HCA $17.5B |
THC $5.1B |
UHS $4.0B |
DVA $3.3B |
CYH $3.1B |
EHC $1.4B |
OPCH $1.3B |
ENSG $1.1B |
ACHC $815.6M |
SGRY $770.4M |
AMN $687.5M |
AMED $587.7M |
USPH $168.0M |
Quarterly Earnings Growth | -13% | 9/13 | THC 574% |
ACHC 131% |
AMED 60% |
UHS 55% |
EHC 38% |
ENSG 23% |
HCA 18% |
OPCH -4% |
DVA -13% |
USPH -21% |
AMN -87% |
SGRY -188% |
CYH -330% |
Annual Earnings Growth | 6% | 7/13 | ACHC 34630% |
THC 726% |
AMED 159% |
UHS 51% |
EHC 33% |
HCA 27% |
DVA 6% |
ENSG -6% |
USPH -36% |
OPCH -48% |
AMN -78% |
CYH -94% |
SGRY -101% |
Quarterly Revenue Growth | 5% | 10/13 | OPCH 17% |
ENSG 15% |
SGRY 14% |
EHC 13% |
USPH 12% |
UHS 11% |
ACHC 9% |
HCA 8% |
AMED 6% |
DVA 5% |
THC 1% |
CYH 0% |
AMN -19% |
Annual Revenue Growth | 4% | 9/13 | SGRY 12% |
OPCH 11% |
EHC 10% |
ENSG 10% |
HCA 9% |
UHS 9% |
ACHC 6% |
AMED 5% |
DVA 4% |
THC 3% |
USPH 3% |
CYH 1% |
AMN -20% |
Cash On Hand | $1.1 Billion | 3/13 | THC $4.1B |
HCA $2.9B |
DVA $1.1B |
ENSG $532.1M |
OPCH $483.0M |
AMED $245.5M |
SGRY $221.8M |
USPH $117.0M |
UHS $106.1M |
EHC $85.4M |
ACHC $82.1M |
CYH $33.0M |
AMN $30.6M |
Short Term Debt | $296.3 Million | 2/13 | HCA $4.7B |
DVA $296.3M |
EHC $164.9M |
CYH $133.0M |
UHS $111.2M |
SGRY $97.3M |
THC $95.0M |
USPH $79.3M |
ACHC $71.7M |
AMED $63.9M |
OPCH $6.5M |
ENSG $4.1M |
AMN -$0 |
Long Term Debt | $9.3 Billion | 4/13 | HCA $38.3B |
THC $12.8B |
CYH $12.0B |
DVA $9.3B |
UHS $5.0B |
SGRY $3.4B |
ACHC $1.8B |
OPCH $1.1B |
AMN $845.6M |
AMED $404.6M |
EHC $189.7M |
USPH $154.5M |
ENSG $142.6M |
PE | 17.04 | 7/13 | USPH 64.75 |
ENSG 30.20 |
OPCH 25.96 |
AMED 23.80 |
EHC 21.67 |
AMN 17.19 |
DVA 17.04 |
HCA 14.28 |
ACHC 13.66 |
UHS 11.52 |
THC 3.09 |
CYH -1.00 |
SGRY -1.00 |
PS | 1.11 | 8/13 | USPH 2.06 |
EHC 1.84 |
ENSG 1.78 |
AMED 1.31 |
ACHC 1.23 |
HCA 1.22 |
OPCH 1.14 |
DVA 1.11 |
SGRY 1.10 |
UHS 0.77 |
THC 0.57 |
AMN 0.30 |
CYH 0.04 |
PB | 6.35 | 2/13 | HCA 107.73 |
DVA 6.35 |
ENSG 4.14 |
OPCH 3.80 |
EHC 3.47 |
AMED 2.53 |
USPH 1.92 |
UHS 1.77 |
SGRY 1.73 |
THC 1.49 |
ACHC 1.22 |
AMN 1.02 |
CYH 0.00 |
PC | 13.17 | 9/13 | EHC 115.65 |
UHS 111.46 |
ACHC 46.68 |
AMN 29.85 |
HCA 29.32 |
SGRY 14.76 |
CYH 13.73 |
ENSG 13.62 |
DVA 13.17 |
AMED 12.37 |
OPCH 11.22 |
USPH 10.98 |
THC 2.93 |
Liabilities to Equity | 39.52 | 1/13 | DVA 39.52 |
THC 5.55 |
SGRY 2.97 |
AMN 2.00 |
ENSG 1.65 |
OPCH 1.40 |
EHC 1.32 |
UHS 1.15 |
ACHC 0.90 |
AMED 0.82 |
USPH 0.74 |
CYH 0.00 |
HCA 0.00 |
ROA | 0.05 | 7/13 | THC 13% | HCA 10% | UHS 7% | EHC 7% | AMED 6% | OPCH 6% | DVA 5% | ACHC 5% | ENSG 5% | AMN 2% | USPH 2% | SGRY 0% | CYH -3% |
ROE | 2.14 | 1/13 | DVA 214% |
THC 101% |
CYH 31% |
EHC 16% |
UHS 15% |
OPCH 15% |
ENSG 14% |
AMED 11% |
ACHC 9% |
AMN 6% |
USPH 4% |
SGRY 0% |
HCA -272% |
Current Ratio | 1.15 | 11/13 | USPH 2.87 |
AMED 2.28 |
ACHC 2.15 |
UHS 1.87 |
EHC 1.77 |
OPCH 1.71 |
ENSG 1.61 |
AMN 1.50 |
THC 1.38 |
SGRY 1.34 |
DVA 1.15 |
HCA 1.01 |
CYH 0.92 |
Quick Ratio | 0.07 | 6/13 | USPH 64.75 |
ENSG 30.20 |
OPCH 25.96 |
AMED 23.80 |
EHC 21.67 |
AMN 17.19 |
DVA 17.04 |
HCA 14.28 |
ACHC 13.66 |
UHS 11.52 |
THC 3.09 |
CYH -1.00 |
SGRY -1.00 |
Long Term Debt to Equity | 23.95 | 1/13 | DVA} 23.95 |
THC} 3.33 |
SGRY} 1.78 |
AMN} 0.95 |
OPCH} 0.77 |
UHS} 0.75 |
ACHC} 0.60 |
AMED} 0.35 |
USPH} 0.32 |
ENSG} 0.08 |
EHC} 0.07 |
CYH} -9.44 |
HCA} -17.54 |
Debt to Equity | 24.71 | 1/13 | DVA 24.71 |
THC 3.36 |
SGRY 1.83 |
AMN 0.95 |
OPCH 0.78 |
UHS 0.76 |
ACHC 0.62 |
USPH 0.53 |
AMED 0.41 |
EHC 0.13 |
ENSG 0.08 |
CYH -9.55 |
HCA -19.69 |
Burn Rate | 4.66 | 2/13 | USPH 5.71 |
DVA 4.66 |
ACHC 3.74 |
HCA 2.02 |
SGRY 1.16 |
AMN 1.14 |
CYH 0.04 |
EHC -1.18 |
UHS -3.41 |
ENSG -7.42 |
AMED -26.41 |
THC -28.00 |
OPCH -60.20 |
Cash to Cap | 0.08 | 4/13 | THC 0.34 |
USPH 0.09 |
OPCH 0.09 |
DVA 0.08 |
AMED 0.08 |
CYH 0.07 |
SGRY 0.07 |
ENSG 0.07 |
HCA 0.03 |
AMN 0.03 |
ACHC 0.02 |
UHS 0.01 |
EHC 0.01 |
CCR | 3.13 | 3/13 | AMN 6.79 |
USPH 3.45 |
DVA 3.13 |
OPCH 2.80 |
AMED 2.51 |
HCA 1.83 |
THC 1.23 |
ENSG 1.14 |
UHS 0.32 |
CYH 0.01 |
ACHC -0.40 |
SGRY -1.42 |
EHC |
EV to EBITDA | 32.50 | 10/13 | AMED} 125.37 |
AMN} 77.61 |
USPH} 75.87 |
OPCH} 59.83 |
ENSG} 56.16 |
THC} 46.48 |
HCA} 38.23 |
EHC} 37.65 |
ACHC} 33.88 |
DVA} 32.50 |
UHS} 31.83 |
CYH} -102.85 |
SGRY} -181.37 |
EV to Revenue | 1.78 | 6/13 | USPH 2.28 |
SGRY 2.19 |
EHC 1.89 |
ACHC 1.80 |
HCA 1.79 |
DVA 1.78 |
ENSG 1.68 |
AMED 1.40 |
OPCH 1.27 |
UHS 1.09 |
CYH 1.00 |
THC 0.99 |
AMN 0.56 |